APA
ISEE

American Portfolios Advisors’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

American Portfolios Advisors’s Portfolio ISEE Stock Details ISEE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-50
Closed -$71 – 2801
2019
Q1 		$71 Hold
50
– – ﹤0.01% 2591
2018
Q4 		$60 Hold
50
– – ﹤0.01% 2383
2018
Q3 		$118 Hold
50
– – ﹤0.01% 2386
2018
Q2 		$137 Hold
50
– – ﹤0.01% 2351
2018
Q1 		$137 Hold
50
– – ﹤0.01% 2275
2017
Q4 		$156 Buy
+50
New +$141 ﹤0.01% 2232

Other funds holding ISEE

SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
TA
Tamarack Advisers Carlsbad, California $2.12M AUM 58.09% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

American Portfolios Advisors's ISEE Position: Q2 2019 in Review

American Portfolios Advisors sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q2 2019, closing a stake of 50 shares — an estimated $71 sold.

American Portfolios Advisors first reported a position in ISEE in Q4 2017 and held it in 6 quarters. The position peaked at $156 in Q4 2017. 52 funds tracked by Wall St. Rank hold ISEE as of Q2 2019.

  • American Portfolios Advisors reported no remaining IVERIC bio, Inc. Common Stock position as of Q2 2019 after selling out during the quarter.
  • American Portfolios Advisors sold 50 IVERIC bio, Inc. Common Stock shares in Q2 2019, an estimated $71.
  • American Portfolios Advisors first reported a position in IVERIC bio, Inc. Common Stock in Q4 2017 and held it in 6 quarters.
  • American Portfolios Advisors's IVERIC bio, Inc. Common Stock position peaked at $156 in Q4 2017.
  • 52 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q2 2019.

Based on American Portfolios Advisors's 13F filing for Q2 2019, filed 24 Mar 2023.